主要文件

查看所有文档

Y0001442

N-[(cis-4-Isopropylcyclohexyl)carbonyl]-D-phenylalanine

Name: <I>N</I>-[(<I>cis</I>-4-Isopropylcyclohexyl)carbonyl]-<SC>D</SC>-phenylalanine
Brand: SIAL

European Pharmacopoeia (EP) Reference Standard

别名:

N-[[cis-4-(1-Methylethyl)cyclohexyl]carbonyl]-D-phenylalanine

登录查看组织和合同定价。

选择尺寸

变更视图

关于此项目

经验公式（希尔记法）:

C₁₉H₂₇NO₃

化学文摘社编号:

105816-06-6

分子量:

317.42

NACRES:

NA.24

UNSPSC Code:

41116107

技术服务

需要帮助？我们经验丰富的科学家团队随时乐意为您服务。

让我们为您提供帮助

属性

grade

pharmaceutical primary standard

API family

nateglinide

manufacturer/tradename

EDQM

application(s)

pharmaceutical (small molecule)

format

neat

说明

General description

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.

Application

N-[(cis-4-Isopropylcyclohexyl)carbonyl]-ᴅ-phenylalanine EP Reference standard, intended for use in laboratory tests only as specifically prescribed in the European Pharmacopoeia.

Packaging

The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.

Other Notes

Sales restrictions may apply.

存储类别

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our 文件 section.

如需帮助，请联系客户支持

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

Improved post-prandial ghrelin response by nateglinide or acarbose therapy contributes to glucose stability in Type 2 diabetic patients.

F Zheng et al.

Journal of endocrinological investigation, 36(7), 489-496 (2013-01-18)

Recent studies highlight an important role of ghrelin in glucose homeostasis, while the association between ghrelin regulation and glucose fluctuation is unclear. We compared the effects of two postprandial hypoglycemic agents on ghrelin response and determined the contribution of ghrelin

Effects of changes in potassium with valsartan use on diabetes risk: Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) trial.

Ranee Chatterjee et al.

American journal of hypertension, 26(6), 723-726 (2013-02-19)

Low and low-normal serum potassium is associated with an increased risk of diabetes. We hypothesized that the protective effect of valsartan on diabetes risk could be mediated by its effect of raising serum potassium. We analyzed data from the Nateglinide

Evaluating insulin secretagogues in a humanized mouse model with functional human islets.

Jian Luo et al.

Metabolism: clinical and experimental, 62(1), 90-99 (2012-09-18)

To develop a rapid, easy and clinically relevant in vivo model to evaluate novel insulin secretagogues on human islets, we investigated the effect of insulin secretagogues on functional human islets in a humanized mouse model. Human islets were transplanted under

查看所有相关文献

全球贸易项目编号

货号	GTIN
Y0001442	04061833807842